Inaktiver Wert

Human Genome Sciences Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Human Genome Sciences : ANNOUNCES REQUIRED OFFER TO REPURCHASE IN RESPECT OF ITS 3.00% CONVERTIBLE SENIOR NOTES DUE 2018	03.08.12
Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	26.07.12
Human Genome Sciences : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Human Genome Sciences, Inc.	26.07.12
Human Genome Sciences : Law Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breaches of Fiduciary Duty	20.07.12
Human Genome Sciences : Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.	18.07.12

Sektor

	% 1. Jan.	Kap.
IQVIA HOLDINGS INC.	+1.51%	42.75 Mrd.
LONZA GROUP AG	+49.22%	41.61 Mrd.
MODERNA, INC.	+8.57%	41.34 Mrd.
CELLTRION, INC.	-12.36%	26.59 Mrd.
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12 Mrd.
MEDPACE HOLDINGS, INC.	+29.17%	12.24 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76 Mrd.
UNITED THERAPEUTICS CORPORATION	+6.35%	11 Mrd.